FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Maxwell Nørgaard

Research Profile

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Trine Silkjaer; Anni Aggerholm; Lene Hyldahl Ebbesen; Peter Hokland; Eigil Kjeldsen; Jan Maxwell Nørgaard; Charlotte Guldborg Nyvold
Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia.
Peter de Nully Brown; Niels Abildgård; Peter Gimsing; Hans Hasselbalch; Paw Jensen; Jan Maxwell Nørgaard; Anne Bukh
[The Haematological Corporate Database].
Christopher Veigaard; Jan Maxwell Nørgaard; Eigil Kjeldsen
Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Maxwell Nørgaard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Trine Silkjaer; Anni Aggerholm; Lene Hyldahl Ebbesen; Peter Hokland; Eigil Kjeldsen; Jan Maxwell Nørgaard; Charlotte Guldborg Nyvold
Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia.
European journal of haematology 2013;90(5):385-96.
2012: Peter de Nully Brown; Niels Abildgård; Peter Gimsing; Hans Hasselbalch; Paw Jensen; Jan Maxwell Nørgaard; Anne Bukh
[The Haematological Corporate Database].
Ugeskrift for laeger 2012;174(42):2526.
2011: Christopher Veigaard; Jan Maxwell Nørgaard; Eigil Kjeldsen
Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases.
Cancer genetics 2011;204(9):516-21.
2011: Lars Möllgård; Lars Nilsson; Jan Maxwell Nørgaard; Anna Porwit; Leonie Saft; Marianne Bach Treppendahl; Hanne Vestergaard; Eva Hellström-Lindberg; Jan Astermark; Inge Høgh Dufva; Ingunn Dybedal; Elisabeth Ejerblad; Hege Garelius; Kirsten Grønbæk; Martin Jädersten; Monika Jansson; Lars Kjeldsen; Olle Linder; Eva Hellström Lindberg
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.
Haematologica 2011;96(7):963-71.
2010: Lene Sofie Granfeldt Ostgård; Eigil Kjeldsen; Mette S Holm; Peter De Nully Brown; Bjarne Bach Pedersen; Knud Bendix; Preben Johansen; Jørgen S Kristensen; Jan Maxwell Nørgaard
Reasons for treating secondary AML as de novo AML.
European journal of haematology 2010;85(3):217-26.
2005: Lene Hyldahl Olesen; Anni Aggerholm; Bodil Lind Andersen; Charlotte Guldborg Nyvold; Per Guldberg; Jan Maxwell Nørgaard; Peter Hokland
Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling.
British journal of haematology 2005;131(4):457-67.
2005: Lene Hyldahl Olesen; Charlotte Guldborg Nyvold; Anni Aggerholm; Jan Maxwell Nørgaard; Per Guldberg; Peter Hokland
Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.
European journal of haematology 2005;75(3):185-92.
2004: Jan Maxwell Nørgaard; Lene Hyldahl Olesen; Peter Hokland
Changing picture of cellular drug resistance in human leukemia.
Critical reviews in oncology/hematology 2004;50(1):39-49.
2003: Lene Hyldahl Olesen; Jan Maxwell Nørgaard; N Pallisgaard; A Bukh; Peter Hokland
Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia.
European journal of haematology 2003;70(5):296-303.
2001: Jan Maxwell Nørgaard; Lene Hyldahl Olesen; Gitte Olesen; K Meyer; Jørgen S Kristensen; Knud Bendix; Bent Pedersen; Eigil Kjeldsen; Peter Hokland
FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia.
European journal of haematology 2001;67(4):221-9.
2001: Jan Maxwell Nørgaard; S T Langkjer; Torben Palshof; Bent Pedersen; Peter Hokland
Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia.
European journal of haematology 2001;66(3):160-7.
2000: Jan Maxwell Nørgaard; Peter Hokland
Biology of multiple drug resistance in acute leukemia.
International journal of hematology 2000;72(3):290-7.
2000: Bent Pedersen; Jan Maxwell Nørgaard; B B Pedersen; Niels Clausen; I H Rasmussen; K Thorling
Many unbalanced translocations show duplication of a translocation participant. Clinical and cytogenetic implications in myeloid hematologic malignancies.
American journal of hematology 2000;64(3):161-9.
1999: Jan Maxwell Nørgaard; Gitte Olesen; Jørgen S Kristensen; Bent Pedersen; Peter Hokland
Leukaemia cell drug resistance and prognostic factors in AML.
European journal of haematology 1999;63(4):219-24.
1999: Jan Maxwell Nørgaard; P D Jensen; Knud Bendix; Niels Clausen; Torben Palshof
Relevance of in vitro leukaemia cell survival to short- and long term clinical outcome in AML.
Leukemia & lymphoma 1999;32(3-4):327-37.
1998: Bent Pedersen; C L Andersen; M M Søgaard; Jan Maxwell Nørgaard; Jørn Koch; K Krejci; M Brandsborg; Niels Clausen
Trisomy 10 survival: a literature review and presentation of seven new cases.
Cancer genetics and cytogenetics 1998;103(2):130-2.
1998: Jan Maxwell Nørgaard; A Bukh; S T Langkjer; Niels Clausen; Torben Palshof; Peter Hokland
MDR1 gene expression and drug resistance of AML cells.
British journal of haematology 1998;100(3):534-40.
1996: Jan Maxwell Nørgaard; S T Langkjer; Torben Palshof; Niels Clausen; B Pedersen; Peter Hokland
Relation of blast cell survival and proliferation to chemotherapy resistance in AML.
British journal of haematology 1996;93(4):888-97.
1993: Jan Maxwell Nørgaard; S T Langkjer; J Ellegaard; Torben Palshof; Niels Clausen; Peter Hokland
Synergistic and antagonistic effects of myeloid growth factors on in vitro cellular killing by cytotoxic drugs.
Leukemia research 1993;17(8):689-94.